<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01590420</url>
  </required_header>
  <id_info>
    <org_study_id>Cost-utility of OSAS</org_study_id>
    <nct_id>NCT01590420</nct_id>
  </id_info>
  <brief_title>Cost-utility Study of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Patients</brief_title>
  <official_title>Cost-utility Study of CPAP Treatment in Obstructive Sleep Apnea Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associação Fundo de Incentivo à Pesquisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Associação Fundo de Incentivo à Pesquisa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the cost-utility of continuous positive airway
      pressure (CPAP) therapy in obstructive sleep apnea (OSA) patients in Sao Paulo city, Brazil,
      after 3 years of treatment and to estimate the cost-effectiveness of CPAP on the number of
      medical visits, hospitalizations, medical examinations, used medications, new case incidence
      and cost of traffic accidents and absence from work. It is also designed to estimate
      quality-adjusted extended years of life, and to assess cost-effects of the therapy (device,
      masks, supplies, maintenance/year for membership of professional consulting, electric power)
      on the cost-effectiveness
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OSA is highly prevalent in Sao Paulo city, Brazil. It is associated with significant
      comorbidities. The cost-utility study is important to (1) support decision-making on health
      policies, (2) to incorporate new technologies, (3) implementation of preventive programs and
      policy development assistance in the medical field.

      Probably CPAP treatment in the long-term, will improve health, physical and mental state, and
      especially, reduces spending on public health, demonstrating cost-utility.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>costs of medical events post CPAP treatment</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the health satuts costs post-CPAP treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of hospitalizations</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in medications</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Costs relative to CPAP treatment</measure>
    <time_frame>3 years</time_frame>
    <description>To evaluate the influence of CPAP device on directs health costs</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>CPAP treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000 patients with 3-years CPAP treatment after a PSG titration</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP S8- Scape / Resmed</intervention_name>
    <description>The pressure for treatment is according to PSG titration</description>
    <arm_group_label>CPAP treatment</arm_group_label>
    <other_name>S8 Escape</other_name>
    <other_name>Resmed</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both genders

          -  Aged 30 to 70 years old

          -  AHI &gt; 30 events/hour

        Exclusion Criteria:

          -  Patients residing in other cities and states other than São Paulo / SP / Brazil

          -  Patients with no fixed residence

          -  Previous CPAP contact
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camila F Rizzi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dalva Poyares, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sergio Tufik, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcos F Bosi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Camila F Rizzi, PhD</last_name>
    <phone>+55 (11) 85555049</phone>
    <email>camila.rizzi@unifesp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dalva Poyares, PhD</last_name>
    <phone>+55 (11) 85937418</phone>
    <email>poyares@unifesp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Associação Fundo de Incentivo à Pesquisa</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camila F Rizzi, PhD</last_name>
      <phone>+55 (11) 85555049</phone>
      <email>camila.rizzi@unifesp.br</email>
    </contact>
    <investigator>
      <last_name>Camila F Rizzi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2012</study_first_submitted>
  <study_first_submitted_qc>May 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2012</study_first_posted>
  <last_update_submitted>May 2, 2012</last_update_submitted>
  <last_update_submitted_qc>May 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Associação Fundo de Incentivo à Pesquisa</investigator_affiliation>
    <investigator_full_name>Camila Furtado Rizzi</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>Sleep</keyword>
  <keyword>CPAP</keyword>
  <keyword>Cost</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

